Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Beta LT demonstrates positive results in initial human trials

Sep. 7, 1999

First patient enrolled in York Medical's cancer vaccine trial

Sep. 6, 1999

Immunomedics awarded four grants from the NIH for development of cancer therapies

Sep. 6, 1999

Maxamine combination treatment for AML effective in phase II studies

Sep. 6, 1999

FDA requests modifications to Bexxar BLA

Aug. 31, 1999

Herceptin approved in Canada for breast cancer therapy

Aug. 30, 1999

Berlex acquires marketing rights to Campath

Aug. 25, 1999

Chiron files long-term survival data for Proleukin with the FDA

Aug. 23, 1999

Clinical trials of SRL-172 in lung cancer are progressing

Aug. 20, 1999

Biomira's BLP25 cancer vaccine tested at higher dose and frequency

Aug. 17, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...